Search Contract Opportunities

Service Contract for BSL3 Autoclave at NYHAFL

ID: HFP-2025-129650 • Type: Special Notice • Match:  95%
Opportunity Assistant

Hello! Please let me know your questions about this opportunity. I will answer based on the available opportunity documents.

Please sign-in to link federal registration and award history to assistant. Sign in to upload a capability statement or catalogue for your company

Some suggestions:
Please summarize the work to be completed under this opportunity
Draft a response outline indicating that my company is also capable of performing this sole source work
Do the documents mention an incumbent contractor?
I'd like to anonymously submit a question to the procurement officer(s)

Description

The U.S. Food and Drug Administration (FDA) New York Human and Animal Food Laboratory (NYHAFL) conducts sample analysis on human and animal foods. The BSL3 laboratory requires a fully functional autoclave to decontaminate all waste and any other materials being removed and discarded from the BSL3. The BSL3 autoclave must be maintained in a constant state of operation and must be repaired as needed. It is necessary that the autoclave be on a preventive maintenance plan that helps to reduce the risk of equipment failure and downtime and to maximize equipment uptime and proper function.

Background
The U.S. Food and Drug Administration (FDA) New York Human and Animal Food Laboratory (NYHAFL) conducts sample analysis on human and animal foods. The laboratory requires a fully functional autoclave to decontaminate all waste and materials being removed from the BSL3 laboratory.

Steris Corporation, located at 5960 Heisley Rd., Mentor, OH 44060, is the sole source provider for this service contract due to their unique capability in maintaining the necessary equipment as per FDA certified methodology and ISO 17025 accreditation requirements.

Work Details
The contract involves a service agreement for the maintenance of a BSL3 autoclave, which includes:
- Preventive maintenance plan to reduce equipment failure risk and maximize uptime.
- Repairs as needed to ensure constant operation.
- Maintenance must comply with FDA certified methodology in accordance with ISO 17025 accreditation standards.
- The autoclave is essential for conducting work in the BSL3 laboratory, particularly in public health emergencies requiring sample analysis.
Show All

Overview

Agency
Food and Drug Administration (FDA) [HHS]
Response Deadline
Sept. 4, 2025, 10:00 a.m. EDT Past Due
Posted
Aug. 28, 2025, 10:42 a.m. EDT
Set Aside
None
NAICS
334516 - Analytical Laboratory Instrument Manufacturing
PSC
6640 - Laboratory Equipment And Supplies
Place of Performance
Jamaica, NY 11433 United States
Source
Open
Current SBA Size Standard
1000 Employees
Pricing
Fixed Price
Est. Level of Competition
Sole Source
On 8/28/25 Food and Drug Administration issued Special Notice HFP-2025-129650 for Service Contract for BSL3 Autoclave at NYHAFL due 9/4/25.
Primary Contact
Name
Erika Crawford   Profile
Email
erika.crawford@fda.hhs.gov
Phone
(301) 796-0298

Documents

Posted documents for Special Notice HFP-2025-129650

Question & Answer

The AI Q&A Assistant has moved to the bottom right of the page

Incumbent or Similar Awards

Contracts Similar to Special Notice HFP-2025-129650

Potential Bidders and Partners

Awardees that have won contracts similar to Special Notice HFP-2025-129650

Similar Active Opportunities

Open contract opportunities similar to Special Notice HFP-2025-129650

Additional Details

Source Agency Hierarchy
HEALTH AND HUMAN SERVICES, DEPARTMENT OF > FOOD AND DRUG ADMINISTRATION > FDA OFFICE OF ACQ GRANT SVCS
FPDS Organization Code
7524-00223
Source Organization Code
100188033
Last Updated
Aug. 28, 2025
Last Updated By
erika.crawford@fda.hhs.gov
Archive Date
Sept. 19, 2025